Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £3.24m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

Trading Update

7 Oct 2021 07:00

RNS Number : 2746O
Thruvision Group PLC
07 October 2021
 

7 October 2021

 

Thruvision Group plc

 

("Thruvision" or the "Group")

 

Trading Update

 

 

Thruvision (AIM:THRU), the leading provider of "safe distance" people-screening technology to the international security market, is pleased to provide an update on trading for the six months ended 30 September 2021.

 

Revenues for the period are expected to be £2.0 million (H1FY21 £4.7 million, H2FY21 £2.0 million). The reduction reflects the fact that last year's comparative included a material order (of £3.0 million) from US Customs and Border Protection (CBP) as described in the results announcement at the time. The period under review did not benefit from a similar order, although, as set out below, we are in ongoing discussions with CBP about potential orders for the second half.

 

Profit Protection

 

Profit Protection revenues grew strongly, by 67%, to £1.0 million (H1FY21 £0.6 million), driven by repeat orders from customers who first purchased from us in the last 12 months. As we explained in our recent Annual Report, we believe that Profit Protection is an important growth market where, in October alone, sales are to expected to exceed those of the entire the first half as our customers prepare for Christmas trading. We are particularly pleased with the high levels of interest in our offering in the strategically important US Profit Protection market where, as well as reducing staff theft, organisations are seeking to improve work place safety after a number of fatal gun-related incidents in distribution centres.

 

US Customs

 

Driven by significant immigration pressure on the southern border with Mexico, our activity levels with CBP are currently very high. Many hundreds of officers are now proficient in using our technology to check immigrants for contraband and weapons at more than 20 locations on the border. With this firm operational base established, we are in discussions about upgrading and expanding the Thruvision fleet more widely across CBP and expect further order flow in the second half as a result.

 

Aviation

 

In Aviation, which has of course been hugely impacted by Covid-19, we have continued to make progress towards US Transportation Security Administration (TSA) accreditation. Such accreditation would enable the use of Thruvision for passenger security screening in US airports. As passenger numbers recover and travel processes permanently adapt to Covid-19, we expect to see renewed interest in our technology given its inherent 'safe distance / no touch' capabilities.

 

International

 

We received no orders in the period from Asia or the Middle East, but have seen continued interest in our technology and we remain optimistic that our business in these regions will recover as more normal trading conditions return.

 

Outlook

 

We continue to manage costs carefully and effectively, with cash of £4.1 million on 30 September 2021 (31 March 2021: £7.3 million). A build-up in our stock levels to support our Profit Protection customers' busy period accounted for £0.9 million of the reduction since the start of the period, with this inventory now allowing us to deliver the strong October sales as described above.

 

Looking forward, we expect to maintain our strong growth rate in Profit Protection across the UK, US and Europe. We also expect to make material progress in expanding our remit with CBP and, in the medium term, win business with further Customs agencies globally. Subject to continued positive progress with TSA, we still see clear longer-term opportunities for our technology in the Aviation sector.

 

 

For further information please contact:

 

Thruvision Group plc +44 (0)1235 425400

Tom Black, Executive Chairman

Colin Evans, Chief Executive

 

Investec Investment Banking (NOMAD & Broker) +44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

 

FTI Consulting LLP +44 (0)20 3727 1000

Matt Dixon / Tom Blundell

 

About Thruvision

Addressing the urgent need for "safe distance" people security screening in the COVID era, Thruvision is uniquely capable of detecting metallic and non-metallic items including weapons, explosives and contraband items that are hidden under clothing, at distances between 3 and 10m. Using patented passive terahertz technology, Thruvision completely removes the need for physical "pat-downs" and has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for aviation security, retail supply chain loss prevention, customs and border control, and public area security. The company has offices near Oxford, and Washington DC.

 

 

www.thruvision.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFDIFLRIIL
Date   Source Headline
4th Apr 20227:00 amRNSYear End Trading Update and Board Changes
1st Apr 20227:01 amRNSBlocklisting update
1st Apr 20227:00 amRNSBlocklisting update
9th Mar 202212:40 pmRNSDirector Share Dealing
21st Feb 20222:07 pmRNSExercise of Sharesave Share Options
25th Jan 20224:06 pmRNSSharesave option grant to Executive Director
24th Dec 20217:00 amRNSDirector Share Dealing
22nd Dec 202112:42 pmRNSHolding(s) in Company
2nd Dec 20216:00 pmRNSDirector Share Dealing
2nd Dec 20212:00 pmRNSInvestor Presentation
1st Dec 202111:36 amRNSDirector Share Dealing
30th Nov 20215:39 pmRNSAward of Share Options to Executive Directors
30th Nov 20211:50 pmRNSDirector Share Dealing
22nd Nov 20217:00 amRNSInterim Results
11th Nov 20217:00 amRNSNotice of Interim Results
27th Oct 20218:52 amRNSBlocklisting application
7th Oct 20217:00 amRNSTrading Update
4th Oct 20219:10 amRNSBlocklisting update
28th Sep 202110:31 amRNSResult of Annual General Meeting
2nd Sep 20217:00 amRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSDirector Share Dealing
27th Jul 20211:00 pmRNSDirector/PDMR Shareholding
16th Jul 20213:27 pmRNSReplacement: Holding(s) in Company
15th Jul 20214:43 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSResults for the Year ended 31 March 2021
9th Jul 20212:34 pmRNSReplacement: Investor Presentation
9th Jul 202111:00 amRNSInvestor Presentation
5th Jul 202112:00 pmRNSNotice of Results
27th May 20211:24 pmRNSDirector Share Dealing
1st Apr 20217:00 amRNSPre-Close Statement
31st Mar 20213:00 pmRNSBlocklisting update
11th Mar 20215:53 pmRNSHolding(s) in Company
10th Mar 20213:33 pmRNSHolding(s) in Company
24th Feb 20217:00 amRNSAppointment of Non-Executive Director
1st Dec 20207:00 amRNSThruvision Investor Presentation
23rd Nov 20207:00 amRNSInterim Results
10th Nov 20207:00 amRNSNotice of Interim Results
9th Oct 202010:18 amRNSHolding(s) in Company
7th Oct 20207:00 amRNSPre-close Trading Update
22nd Sep 202010:31 amRNSResult of Annual General Meeting
18th Sep 20207:00 amRNSContract award announcement
26th Jun 202010:32 amRNSHolding(s) in Company
23rd Jun 20205:21 pmRNSHolding(s) in Company
22nd Jun 20204:24 pmRNSHolding(s) in Company
17th Jun 202011:05 amRNSSecond Price Monitoring Extn
17th Jun 202011:01 amRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSAward of Share Options to Executive Directors
8th Jun 20207:00 amRNSResults for the Year ended 31 March 2020
3rd Jun 20207:22 amRNSNotice of Annual Results
3rd Jun 20207:00 amRNSNotice of Annual Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.